Clinic
Spero Health of Tennessee, LLC
Spero Health of Tennessee, LLC was paid $23.45M by Medicaid between Nov 2019 and Dec 2024, across 13 billing codes. Its largest line is H0016, Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) — 40% of everything it billed.
33Billing provider infoSPERO HEALTH OF TENNESSEE, LLC
SMYRNA, TN 37167
SMYRNA, TN 37167
33aNPI1538628904assigned 03/15/2019
33bProvider typeSubstance Use Disorder Rehabilitation Clinic/Center
28Total paid$23.45M
24GClaims123,208
24DCodes billed13
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other Substance Use Disorder Rehabilitation Clinic/Center providers in Tennessee
Rank by total paid#2 of 30
Median peer was paid$1.03M
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 17 | $3K | |
| 2020 | 2,317 | $539K | |
| 2021 | 21,276 | $4.57M | |
| 2022 | 31,720 | $6.70M | |
| 2023 | 31,056 | $6.48M | |
| 2024incomplete | 36,822 | $5.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 40% | 42,055 | 34,801 | $9.44M |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | 27% | 24,412 | 13,946 | $6.42M |
| H0033 | Oral medication administration, direct observation | 25% | 34,910 | 26,451 | $5.91M |
| H0047 | Alcohol and/or other drug abuse services, not otherwise specified | 4.1% | 2,085 | 1,939 | $970K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.3% | 5,013 | 4,274 | $304K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 4,470 | 3,813 | $228K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,714 | 3,054 | $115K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 2,294 | 1,902 | $22K |
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | <1% | 1,254 | 1,026 | $19K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 1,438 | 960 | $12K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 659 | 589 | $8K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 861 | 636 | $6K |
1 more codes
| 96160 | <1% | 43 | $0.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialADAMS, RICK (CFO)